Skip to Main content Skip to Navigation
Journal articles

Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study

Abstract : Purpose: There is still controversy on brand-to-generic (B-G) antiepileptic drugs (AEDs) substitution. Methods: To assess association between B-G AED substitution and seizure-related hospitalization, we designed a case crossover using the French National Health Insurance Database. We identified a cohort of adult patients who filled a prescription in 2009–2011 for AEDs with at least one brand name and one generic form. The outcome date was defined as the date of hospitalization, coded G40.x or G41.x, with a G40/G41 hospitalization-free period of at least 1 year. Patients with a medical history of cancer and women who gave birth in 2009–2011 were excluded. We required individuals to have regular dispensations of AEDs within the year preceding the outcome date. Free patients were defined as patients who had only brand name dispensations before the control period.Results: Eight thousand three hundred seventy nine patients (mean age ± standard deviation, 52.7 ± 18.8 years; sex ratio male/female, 1.27) were analyzed. Discordant pairs were 491 with B-G substitution in the control period only and 478 with B-G substitution in the case period only; odds ratio (95% confidence interval) 0.97 (0.86–1.10). No statistically significant interaction was detected among the four prespecified subgroup analyses (gender, age strata, free or non-free, and strict AED monotherapy or not). Controlling for non-seizure-related hospitalizations made no material difference. Sensitivity analyses yielded similar results.Conclusions: Brand-to-generic AED substitution was not associated with an elevated risk of seizure-related hospitalization.
Document type :
Journal articles
Complete list of metadatas

Cited literature [23 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01269917
Contributor : Laurent Jonchère <>
Submitted on : Monday, May 2, 2016 - 3:25:26 PM
Last modification on : Friday, October 23, 2020 - 4:37:20 PM
Long-term archiving on: : Tuesday, May 24, 2016 - 5:47:28 PM

File

Brand name to generic substitu...
Files produced by the author(s)

Identifiers

Citation

Elisabeth Polard, Emmanuel Nowak, André Happe, Arnaud Biraben, Emmanuel Oger. Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study. Pharmacoepidemiology and Drug Safety, Wiley, 2015, 24 (11), pp.1161-1169. ⟨10.1002/pds.3879⟩. ⟨hal-01269917⟩

Share

Metrics

Record views

586

Files downloads

539